Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838–40. Clinical Utility of Trial-estimated Prognostic Models
2017 ◽
Vol 72
(3)
◽
pp. e70-e71
Fatemeh Seyednasrollah
◽
Mehrad Mahmoudian
◽
Liisa Rautakorpi
◽
Outi Hirvonen
◽
Tarja Laitinen
◽
...